- Home
- NAMS vs SHOO Comparison
NAMS vs SHOO Comparison
Compare NAMS & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- SHOO
- Stock Information
- Founded
- NAMS 2019
- SHOO 1990
- Country
- NAMS Netherlands
- SHOO United States
- Employees
- NAMS N/A
- SHOO N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- SHOO Shoe Manufacturing
- Sector
- NAMS Health Care
- SHOO Consumer Discretionary
- Exchange
- NAMS Nasdaq
- SHOO Nasdaq
- Market Cap
- NAMS 2.7B
- SHOO 2.0B
- IPO Year
- NAMS N/A
- SHOO 1993
- Fundamental
- Price
- NAMS $24.49
- SHOO $32.49
- Analyst Decision
- NAMS Strong Buy
- SHOO Hold
- Analyst Count
- NAMS 10
- SHOO 7
- Target Price
- NAMS $41.40
- SHOO $27.83
- AVG Volume (30 Days)
- NAMS 982.1K
- SHOO 1.4M
- Earning Date
- NAMS 11-05-2025
- SHOO 11-06-2025
- Dividend Yield
- NAMS N/A
- SHOO 2.60%
- EPS Growth
- NAMS N/A
- SHOO N/A
- EPS
- NAMS N/A
- SHOO 1.28
- Revenue
- NAMS $64,006,000.00
- SHOO $2,319,527,000.00
- Revenue This Year
- NAMS N/A
- SHOO $11.61
- Revenue Next Year
- NAMS $1.67
- SHOO $10.13
- P/E Ratio
- NAMS N/A
- SHOO $25.37
- Revenue Growth
- NAMS 762.15
- SHOO 7.97
- 52 Week Low
- NAMS $14.06
- SHOO $19.05
- 52 Week High
- NAMS $27.35
- SHOO $50.01
- Technical
- Relative Strength Index (RSI)
- NAMS 48.92
- SHOO 72.80
- Support Level
- NAMS $23.05
- SHOO $30.70
- Resistance Level
- NAMS $27.35
- SHOO $32.02
- Average True Range (ATR)
- NAMS 1.46
- SHOO 1.11
- MACD
- NAMS -0.24
- SHOO 0.15
- Stochastic Oscillator
- NAMS 33.49
- SHOO 84.73
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.